A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate Fleischmann, R., Pangan, A. L., Mysler, E., Bessette, L., Peterfy, C., Durez, P., Ostor, A., Li, Y., Zhou, Y., Othman, A. A., Song, I., Genovese, M. C. WILEY. 2018

View details for Web of Science ID 000447268901423